| 發表時間 |
文章標題 |
人氣 |
| 2013-01-28 |
[Medscape][FDA Approvals]FDA Licenses Diabetes Drug Alogliptin, in 3 Formulations
|
(139) |
| 2013-01-03 |
[Medscape][FDA Approvals]Inhalant Approved for Agitation in Bipolar I, Schizophrenia
|
(69) |
| 2013-01-02 |
[Medscape][FDA Approvals]FDA Approves Varizig to Reduce Chickenpox Symptoms
|
(110) |
| 2013-01-01 |
[Medscape][FDA Approvals]FDA Approves Bedaquiline for Resistant TB Treatment
|
(92) |
| 2012-12-30 |
[Medscape][FDA Approvals]FDA Approves Apixaban to Prevent Stroke in Nonvalvular AF
|
(345) |
| 2012-10-26 |
[Medscape][FDA Approvals]FDA Approves Perampanel for Partial-Onset Seizures
|
(167) |
| 2012-10-19 |
[Medscape][Medical News]FDA Approves Ocriplasmin for Vitreomacular Adhesions
|
(134) |
| 2012-10-02 |
[Medscape][Medical News][FDA Approvals]FDA Approves Adalimumab for Ulcerative Colitis
|
(143) |
| 2012-09-30 |
[FDA Approvals]FDA Approves Regorafenib for Metastatic Colorectal Cancer
|
(235) |
| 2012-09-18 |
[Medscape][Medical News][FDA Approvals]New Option for Constipation: FDA Approves Linaclotide
|
(1050) |
| 2012-09-17 |
[Medscape][FDA Approvals]A 4th Option for CML: FDA Grants Approval for Bosutinib
|
(120) |
| 2012-09-16 |
[Medscape][Medical News][FDA Approvals]FDA Approves Second Oral Drug(teriflunomide (Aubagio)) for MS
|
(98) |
| 2012-03-02 |
[Medscape][Medscape Alerts][Medscape Medical News]FDA: Avoid Use of Kaletra Oral Solution in Newborns
|
(125) |
| 2012-02-22 |
[Medscape][FDA Approvals][Medscape Education Clinical Briefs]FDA Approves Drug to Curb Risk for Preterm Birth
|
(72) |
| 2012-01-20 |
[FDA Approvals]Dapagliflozin Declined by FDA
|
(411) |
| 2011-12-23 |
[FDA approval]Baxter receives FDA approval for ADVATE to prevent hemophilia A
|
(155) |
| 2011-12-20 |
[FDA approval]FDA approves first drug(Jakafi (ruxolitinib)) to treat a rare bone marrow disease
|
(396) |
| 2011-12-19 |
[FDA approval]FDA approves first insomnia drug(Intermezzo) for middle-of-the-night waking followed by difficulty returning to sleep
|
(145) |
| 2011-12-18 |
[FDA approval]FDA approves Eylea for eye disorder in older people
|
(245) |
| 2011-10-26 |
[FDA Medwatch]Xigris [drotrecogin alfa (activated)]: Market Withdrawal - Failure to Show Survival Benefit
|
(348) |
| 2011-10-11 |
[Medscape][FDA Approvals]Tadalafil Approved for Benign Prostatic Hyperplasia
|
(225) |
| 2011-09-28 |
[FDA][Postmarket Drug Safety Information for Patients and Providers]Questions and Answers - Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone
|
(231) |
| 2011-09-03 |
[Drug Safety and Availability]FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate)
|
(157) |
| 2011-09-01 |
[FDA Approvals]FDA Approves Brentuximab for Refractory Lymphomas
|
(167) |
| 2011-08-28 |
[FDA Approvals]FDA Approves crizotinib (Xalkori, Pfizer) for Advanced NSCLC
|
(910) |
| 2011-08-27 |
[FDA]Safe Use Initiative: Acetaminophen Toxicity
|
(377) |
| 2011-06-30 |
[Medscape Medical News][FDA Approvals]FDA Approves New Drug（Rectiv) for Chronic Anal Fissure Pain FDA核准治療肛裂用藥膏
|
(357) |
| 2011-06-28 |
[Medscape Medical News][FDA Approvals]FDA Okays First Autologous Filler for Smile Lines
|
(63) |
| 2011-06-21 |
[FDA Approvals]FDA Approves Ezogabine for Seizures in Adults
|
(211) |
| 2011-06-19 |
[FDA Approvals]Injectable Gel for Fecal Incontinence Wins FDA Approval
|
(152) |
| 2011-06-17 |
[Drug Safety and Availability]FDA Drug Safety Communication: Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease
|
(215) |
| 2011-06-13 |
[FDA Review Concludes] No Cancer Risk With ARBs
|
(117) |
| 2011-06-10 |
[Drug Safety and Availability]Questions and Answers:5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer
|
(305) |
| 2011-06-09 |
[FDA Approves] Once-Daily Rilpivirine for HIV Infection
|
(277) |
| 2011-05-04 |
FDA Approves New Drug (linagliptin) for Type 2 Diabetes
|
(552) |
| 2011-04-30 |
FDA Drug Safety Communication: Safety update on Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
|
(306) |
| 2011-04-24 |
[FDA Approvals]Fidaxomicin Noninferior to Vancomycin for Treatment of C Difficile Infection
|
(436) |
| 2011-04-22 |
[PDR Drug Alert]Serious Risks of QT prolongation, Torsades de pointes and Sudden death for vandetanib; FDA required restricted distribution program.
|
(173) |
| 2011-04-10 |
[FDA Medwatch]Benzocaine Topical Products: Sprays, Gels and Liquids - Risk of Methemoglobinemia(變性血紅素血症)
|
(320) |
| 2011-03-31 |
FDA Drug Safety Communication: Special storage and handling requirements must be followed for Pradaxa (dabigatran etexilate mesylate) capsules
|
(331) |
| 2011-03-26 |
FDA Approves Ipilimumab for Advanced Melanoma
|
(672) |
| 2011-03-08 |
[FDA drug safety]FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)
|
(259) |
| 2011-03-05 |
FDA Approves COPD Drug Opposed by Advisory Panel
|
(157) |
| 2011-03-04 |
[Enforcement Activities by FDA]Unapproved Prescription Cough, Cold, and Allergy Products
|
(952) |
| 2011-02-20 |
FDA Warns Against Use of Terbutaline to Treat Preterm Labor
|
(193) |
| 2011-02-09 |
[FDA Drug Safety] Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients
|
(184) |
| 2010-12-25 |
FDA Drug Safety Communication: Ongoing safety review of Recombinant Human Growth Hormone (somatropin) and possible increased risk of death
|
(399) |
| 2010-12-16 |
FDA Drug Safety Communication: Death resulting from overdose after accidental ingestion of Tessalon (benzonatate) by children under 10 years of age
|
(289) |
| 2010-10-30 |
[FDA medwatch]Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone
|
(703) |
| 2010-10-25 |
[FDA medwatch]Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified
|
(332) |
// 如果你希望圖片繼續多一點，那就自己再複製增加
醫藥類 (14)
